<VariationArchive VariationID="1048416" VariationName="NM_000512.5(GALNS):c.604del (p.Glu202fs)" VariationType="Deletion" Accession="VCV001048416" Version="12" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-02-20" DateCreated="2021-05-10" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1036298" VariationID="1048416">
      <GeneList>
        <Gene Symbol="GALNS" FullName="galactosamine (N-acetyl)-6-sulfatase" GeneID="2588" HGNC_ID="HGNC:4122" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="88813734" stop="88856947" display_start="88813734" display_stop="88856947" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="88880141" stop="88923373" display_start="88880141" display_stop="88923373" Strand="-" />
          </Location>
          <OMIM>612222</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000512.5(GALNS):c.604del (p.Glu202fs)</Name>
      <CanonicalSPDI>NC_000016.10:88836229:CCCCC:CCCC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16q24.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="88836230" stop="88836230" display_start="88836230" display_stop="88836230" variantLength="1" positionVCF="88836229" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="88902638" stop="88902638" display_start="88902638" display_stop="88902638" variantLength="1" positionVCF="88902637" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>E17fs</ProteinChange>
      <ProteinChange>E202fs</ProteinChange>
      <ProteinChange>E208fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.88836234del" Assembly="GRCh38">
            <Expression>NC_000016.10:g.88836234del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.88902642del" Assembly="GRCh37">
            <Expression>NC_000016.9:g.88902642del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008667.1" sequenceAccession="NG_008667" sequenceVersion="1" change="g.25737del">
            <Expression>NG_008667.1:g.25737del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000512.5" sequenceAccession="NM_000512" sequenceVersion="5" change="c.604del" MANESelect="true">
            <Expression>NM_000512.5:c.604del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000503.1" sequenceAccession="NP_000503" sequenceVersion="1" change="p.Glu202fs">
            <Expression>NP_000503.1:p.Glu202fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001323543.2" sequenceAccession="NM_001323543" sequenceVersion="2" change="c.49del">
            <Expression>NM_001323543.2:c.49del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001310472.1" sequenceAccession="NP_001310472" sequenceVersion="1" change="p.Glu17fs">
            <Expression>NP_001310472.1:p.Glu17fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001323544.2" sequenceAccession="NM_001323544" sequenceVersion="2" change="c.622del">
            <Expression>NM_001323544.2:c.622del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001310473.1" sequenceAccession="NP_001310473" sequenceVersion="1" change="p.Glu208fs">
            <Expression>NP_001310473.1:p.Glu208fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1382823339" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000512.5(GALNS):c.604del (p.Glu202fs) AND Mucopolysaccharidosis, MPS-IV-A" Accession="RCV001384617" Version="11">
        <ClassifiedConditionList TraitSetID="175">
          <ClassifiedCondition DB="MedGen" ID="C0086651">Mucopolysaccharidosis, MPS-IV-A</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-07-24" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-07-24" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2021-05-10" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12442278</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15235041</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24726177</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25252036</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">34387910</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="175" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3036" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Mucopolysaccharidosis type IV A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">MPS IVA</ElementValue>
                <XRef Type="MIM" ID="253000" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Morquio syndrome A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">MPS 4A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Morquio A disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Galactosamine-6-sulfatase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Morquio syndrome A, mild</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Mucopolysaccharidosis, MPS-IV-A</ElementValue>
                <XRef ID="Morquio+syndrome+A/4876" DB="Genetic Alliance" />
                <XRef ID="7259005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mucopolysaccharidosis Type IVA</ElementValue>
                <XRef ID="NBK148668" DB="GeneReviews" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MPS4A</ElementValue>
                <XRef Type="MIM" ID="253000" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The phenotypic spectrum of mucopolysaccharidosis IVA (MPS IVA) is a continuum that ranges from a severe and rapidly progressive early-onset form to a slowly progressive later-onset form. Children with MPS IVA typically have no distinctive clinical findings at birth. The severe form is usually apparent between ages one and three years, often first manifesting as kyphoscoliosis, genu valgum (knock-knee), and pectus carinatum; the slowly progressive form may not become evident until late childhood or adolescence, often first manifesting as hip problems (pain, stiffness, and Legg Perthes disease). Progressive bone and joint involvement leads to short stature, and eventually to disabling pain and arthritis. Involvement of other organ systems can lead to significant morbidity, including respiratory compromise, obstructive sleep apnea, valvular heart disease, hearing impairment, visual impairment from corneal clouding, dental abnormalities, and hepatomegaly. Compression of the spinal cord is a common complication that results in neurologic impairment. Children with MPS IVA have normal intellectual abilities at the outset of the disease.</Attribute>
                <XRef ID="NBK148668" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3785" />
                <XRef ID="3785" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23844448</ID>
                <ID Source="BookShelf">NBK148668</ID>
              </Citation>
              <XRef ID="309297" DB="Orphanet" />
              <XRef ID="582" DB="Orphanet" />
              <XRef ID="C0086651" DB="MedGen" />
              <XRef ID="MONDO:0009659" DB="MONDO" />
              <XRef Type="MIM" ID="253000" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3047828" SubmissionDate="2021-10-28" DateLastUpdated="2021-10-30" DateCreated="2021-08-25">
        <ClinVarSubmissionID localKey="NM_000512.5:c.604del|OMIM:253000" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV001547751" DateUpdated="2021-10-30" DateCreated="2021-08-25" Type="SCV" Version="3" SubmitterName="Laboratory of Diagnosis and Therapy of Lysosomal Disorders, University of Padova" OrgID="506414" OrganizationCategory="laboratory" OrgAbbreviation="LAB-DTLD" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-02-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15235041</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24726177</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25252036</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">34387910</ID>
          </Citation>
          <Comment>Frameshift variant (PVS1_very strong); in vivo functional studies supportive of a damaging effect on the gene product (low to null enzymatic activity in homozygotes; PS3_supporting); the prevalence of the variant in affected individuals is significantly increased compared with the prevalence in controls (PS4_strong); very low frequency in gnomAD v2.1.1 (PM2_moderate)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantChromosomes" integerValue="5" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GALNS" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <XRefList>
            <XRef DB="dbSNP" ID="1382823339" Type="rsNumber" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000512.5:c.604del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="253000" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10295861</SubmissionName>
          <SubmissionName>SUB10583943</SubmissionName>
          <SubmissionName>SUB9123788</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4010845" SubmissionDate="2021-12-29" DateLastUpdated="2022-01-03" DateCreated="2022-01-03">
        <ClinVarSubmissionID localKey="NM_000512.5:c.604del|OMIM:253000" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002045017" DateUpdated="2022-01-03" DateCreated="2022-01-03" Type="SCV" Version="1" SubmitterName="Genome-Nilou Lab" OrgID="507598" OrganizationCategory="laboratory" OrgAbbreviation="Genome Nilou" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-11-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>no</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GALNS" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000512.5:c.604del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="253000" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10872261</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3109829" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="4933936|MedGen:C0086651" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001584185" DateUpdated="2024-02-14" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15235041</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12442278</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1048416). This variant is also known as 600delG. This premature translational stop signal has been observed in individual(s) with mucopolysaccharidosis type IVA (PMID: 15235041). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change creates a premature translational stop signal (p.Glu202Lysfs*117) in the GALNS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GALNS are known to be pathogenic (PMID: 12442278).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GALNS" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000016.9:g.88902638del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0086651" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4010845" TraitType="Disease" MappingType="XRef" MappingValue="253000" MappingRef="OMIM">
        <MedGen CUI="C0086651" Name="Mucopolysaccharidosis, MPS-IV-A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3047828" TraitType="Disease" MappingType="XRef" MappingValue="253000" MappingRef="OMIM">
        <MedGen CUI="C0086651" Name="Mucopolysaccharidosis, MPS-IV-A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3109829" TraitType="Disease" MappingType="XRef" MappingValue="C0086651" MappingRef="MedGen">
        <MedGen CUI="C0086651" Name="Mucopolysaccharidosis, MPS-IV-A" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

